<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Lexis, Chris P. H.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Metformin Does Not Improve Diastolic Function in Nondiabetic Patients with STEMI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-21</style></pages><abstract><style  face="normal" font="default" size="100%">Metformin has no effect on diastolic function following acute myocardial infarction (MI) in nondiabetic patients. The disappointing finding from the Glycometabolic Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction trial [GIPS-III; Lexis CP et al. JAMA 2014] is discussed in this article.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>